NGVT stock icon

Ingevity

45.83 USD
-1.22
2.59%
At close Dec 13, 4:00 PM EST
After hours
45.83
+0.00
0.00%
1 day
-2.59%
5 days
1.64%
1 month
0.50%
3 months
18.85%
6 months
-0.15%
Year to date
-2.45%
1 year
6.19%
5 years
-48.10%
10 years
95.02%
 

About: Ingevity Corp is a chemical manufacturer based in the United States. It conducts its operations through three segments, namely Performance Chemicals, Advanced Polymer Technologies, and Performance Materials. The bulk of its revenue is generated by the Performance Chemicals segment which deals with the manufacture and sale of specialty chemicals that find their use in a range of processes such as asphalt paving, oil exploration and production, agrochemicals, adhesives, lubricants, and publication inks. The Performance Materials segment, on the other hand, focuses on automotive carbon products used in automobiles. The Advanced Polymer Technologies segment produces caprolactone and caprolactone-based specialty polymers. The Company generates the majority of its revenue from North America.

Employees: 1,700

0
Funds holding %
of 6,805 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

200% more funds holding in top 10

Funds holding in top 10: 1 [Q2] → 3 (+2) [Q3]

74% more call options, than puts

Call options by funds: $82K | Put options by funds: $47K

13% more repeat investments, than reductions

Existing positions increased: 87 | Existing positions reduced: 77

2.58% more ownership

Funds ownership: 96.51% [Q2] → 99.09% (+2.58%) [Q3]

2% less funds holding

Funds holding: 265 [Q2] → 260 (-5) [Q3]

8% less capital invested

Capital invested by funds: $1.53B [Q2] → $1.4B (-$128M) [Q3]

11% less first-time investments, than exits

New positions opened: 39 | Existing positions closed: 44

Research analyst outlook

2 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$40
13%
downside
Avg. target
$44
5%
downside
High target
$47
3%
upside

2 analyst ratings

positive
0%
neutral
100%
negative
0%
BMO Capital
John McNulty
52% 1-year accuracy
25 / 48 met price target
3%upside
$47
Market Perform
Maintained
31 Oct 2024
BMO Capital
John McNulty
52% 1-year accuracy
25 / 48 met price target
13%downside
$40
Market Perform
Maintained
30 Sept 2024

Financial journalist opinion

Based on 4 articles about NGVT published over the past 30 days

Positive
Zacks Investment Research
2 days ago
Here's Why You Should Add Ingevity Stock to Your Portfolio
NGVT benefits from the repositioning of its Performance Chemicals segment to rationalize its manufacturing footprint and strategic acquisitions.
Here's Why You Should Add Ingevity Stock to Your Portfolio
Neutral
Zacks Investment Research
2 days ago
Zacks Industry Outlook Axalta Coating Systems, Ingevity and AdvanSix
Axalta Coating Systems, Ingevity and AdvanSix have been highlighted in this Industry Outlook article.
Zacks Industry Outlook Axalta Coating Systems, Ingevity and AdvanSix
Neutral
Zacks Investment Research
3 days ago
3 Chemical Specialty Stocks to Watch Amid Industry Challenges
Soft end-market demand dampens the prospects of the Zacks Chemicals Specialty industry. AXTA, NGVT and ASIX are set to gain from strategic actions to navigate the ongoing challenges.
3 Chemical Specialty Stocks to Watch Amid Industry Challenges
Positive
Zacks Investment Research
2 weeks ago
Why Is Ingevity (NGVT) Up 14.6% Since Last Earnings Report?
Ingevity (NGVT) reported earnings 30 days ago. What's next for the stock?
Why Is Ingevity (NGVT) Up 14.6% Since Last Earnings Report?
Positive
Zacks Investment Research
1 month ago
Should Value Investors Buy Ingevity (NGVT) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Should Value Investors Buy Ingevity (NGVT) Stock?
Neutral
Seeking Alpha
1 month ago
Ingevity Corporation (NGVT) Q3 2024 Earnings Call Transcript
Ingevity Corporation (NYSE:NGVT ) Q3 2024 Earnings Call October 30, 2024 10:00 AM ET Company Participants John Nypaver - Investor Relations Luis Fernandez-Moreno - Interim Chief Executive Officer Mary Dean Hall - Chief Financial Officer Ed Woodcock - President, Performance Materials Rich White - President, Performance Chemicals Steve Hulme - President, Advanced Polymer Technologies Conference Call Participants Lee Jagoda - CJS Securities Daniel Rizzo - Jefferies John McNulty - BMO Capital Markets Mike Sison - Wells Fargo Operator Good morning or good afternoon, and welcome to the Ingevity Third Quarter 2024 Earnings Call and Webcast. My name is Adam, and I'll be your operator today.
Ingevity Corporation (NGVT) Q3 2024 Earnings Call Transcript
Neutral
Zacks Investment Research
1 month ago
Ingevity's Earnings Beat Estimates in Q3, Revenues Down Y/Y
The downside in NGVT's Q3 sales is attributable to the repositioning of the Performance Chemicals segment.
Ingevity's Earnings Beat Estimates in Q3, Revenues Down Y/Y
Neutral
Business Wire
1 month ago
Ingevity reports third quarter 2024 financial results
NORTH CHARLESTON, S.C.--(BUSINESS WIRE)--Ingevity Corporation today reported its financial results for the third quarter 2024.
Ingevity reports third quarter 2024 financial results
Neutral
Business Wire
1 month ago
Ingevity updates third-quarter 2024 earnings release and webcast dates
NORTH CHARLESTON, S.C.--(BUSINESS WIRE)--Ingevity announced today that it will release its third-quarter 2024 earnings after the stock market close on Tuesday, October 29, 2024.
Ingevity updates third-quarter 2024 earnings release and webcast dates
Positive
Zacks Investment Research
2 months ago
Ingevity (NGVT) Soars 12.0%: Is Further Upside Left in the Stock?
Ingevity (NGVT) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Ingevity (NGVT) Soars 12.0%: Is Further Upside Left in the Stock?
Charts implemented using Lightweight Charts™